Gerdes J, Schwarting R, Stein H
J Clin Pathol. 1986 Sep;39(9):993-7. doi: 10.1136/jcp.39.9.993.
An improved immunoenzymatic double labelling method was developed, which simultaneously shows the Ki-1 membrane antigen and the nuclear proliferation associated antigen, defined by monoclonal antibody Ki-67. This new approach permits in situ discrimination of cells that are proliferating or not with a particular membrane antigen. Most Ki-1 positive cells in normal lymphoid tissue also express the Ki-67 nuclear antigen and thus appear to be proliferating. As proliferating cells are more susceptible to malignant transformation than quiescent cells, it is possible that the small number of normal Ki-1 positive cells might, none the less, cause a large proportion of all lymphomas in man.
开发了一种改进的免疫酶双标记方法,该方法可同时显示Ki-1膜抗原和由单克隆抗体Ki-67定义的核增殖相关抗原。这种新方法能够在原位区分具有特定膜抗原的增殖细胞和非增殖细胞。正常淋巴组织中大多数Ki-1阳性细胞也表达Ki-67核抗原,因此似乎处于增殖状态。由于增殖细胞比静止细胞更容易发生恶性转化,所以正常的少量Ki-1阳性细胞仍有可能导致人类所有淋巴瘤中的很大一部分。